We’ve got some awful news for some of you – as nearly 600,000 inhalers were just recalled. Producer GlaxoSmithKline recalled them, notes the FDA.
Specific inhalers were “out of specification results for leak rate” and, although the defects are not an immediate danger to users, they are being instructed to return the items.
“We currently don’t anticipate a supply impact to Ventolin HFA 200D inhaler as a result of this issue,” said GSK in according to Reuters.
The specific models of inhalers defected include “Ventiolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalations, net weight 18 g inhalers, RX only.”
“This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate,” said the Food and Drug Administration in a Friday press release.
Learn more about the recall below:
If you enjoyed this article or learned something new, please don’t forget to share it with others so they have a chance to enjoy this free information. This article is open source and free to reblog or use if you give a direct link back to the original article URL. Thanks for taking the time to support an open source initiative. We believe all information should be free and available to everyone. Have a good day and we hope to see you soon!
Please follow and like us: